General information about company |
|||
|---|---|---|---|
| Scrip Code | 506401 | ||
| NSE Symbol | DEEPAKNTR | ||
| MSEI Symbol | NOTLISTED | ||
| ISIN | INE288B01029 | ||
| Name of company | Deepak Nitrite Limited | ||
| Type of company | Main Board | ||
| Class of security | Equity | ||
| Date of start of financial year | 01-Apr-2024 | ||
| Date of end of financial year | 31-Mar-2025 | ||
| Date of board meeting when results were approved | 28-May-2025 | ||
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 12-May-2025 | ||
| Description of presentation currency | INR (in Actuals) | ||
| Reporting Type | Quarterly | ||
| Reporting Quarter | Fourth quarter | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Whether results are audited or unaudited for the quarter ended | Audited | ||
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited | ||
| Segment Reporting | Multi segment | ||
| Description of single segment | |||
| Start date and time of board meeting | 28-May-2025 14:10:00 | ||
| End date and time of board meeting | 28-May-2025 16:00:00 | ||
| Whether cash flow statement is applicable on company | Yes | ||
| Type of cash flow statement | Cash Flow Indirect | ||
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion | ||
Financial Results Ind-AS |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 1 | Income | ||
| Revenue from operations | 21796900000 | 82819300000 | |
| Other income | 227900000 | 838600000 | |
| Total income | 22024800000 | 83657900000 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 14792300000 | 56811600000 |
| (b) | Purchases of stock-in-trade | 184800000 | 1316300000 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 146500000 | -249000000 |
| (d) | Employee benefit expense | 1015900000 | 3921500000 |
| (e) | Finance costs | 93400000 | 275000000 |
| (f) | Depreciation, depletion and amortisation expense | 512500000 | 1953700000 |
| (f) | Other Expenses | ||
| 1 | Power & fuel expenses | 1144500000 | 4635200000 |
| 2 | Other expenses | 1347800000 | 5466100000 |
| Total other expenses | 2492300000 | 10101300000 | |
| Total expenses | 19237700000 | 74130400000 | |
| 3 | Total profit before exceptional items and tax | 2787100000 | 9527500000 |
| 4 | Exceptional items | 0 | 0 |
| 5 | Total profit before tax | 2787100000 | 9527500000 |
| 6 | Tax expense | ||
| 7 | Current tax | 459900000 | 2283300000 |
| 8 | Deferred tax | 302200000 | 270500000 |
| 9 | Total tax expenses | 762100000 | 2553800000 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0 | 0 |
| 11 | Net Profit Loss for the period from continuing operations | 2025000000 | 6973700000 |
| 12 | Profit (loss) from discontinued operations before tax | 0 | 0 |
| 13 | Tax expense of discontinued operations | 0 | 0 |
| 14 | Net profit (loss) from discontinued operation after tax | 0 | 0 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | 0 |
| 16 | Total profit (loss) for period | 2025000000 | 6973700000 |
| 17 | Other comprehensive income net of taxes | -16000000 | -33100000 |
| 18 | Total Comprehensive Income for the period | 2009000000 | 6940600000 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 2024100000 | 6972400000 | |
| Total profit or loss, attributable to non-controlling interests | 900000 | 1300000 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 2010500000 | 6943500000 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | -1500000 | -2900000 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 272800000 | 272800000 | |
| Face value of equity share capital | 2 | 2 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | 0 | |
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 14.84 | 51.12 | |
| Diluted earnings (loss) per share from continuing operations | 14.84 | 51.12 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 14.84 | 51.12 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 14.84 | 51.12 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | ||
Remarks |
|
|---|---|
| Debt equity ratio | |
| Debt service coverage ratio | |
| Interest service coverage ratio | |
Statement of Asset and Liabilities |
|||
|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-Apr-2024 | ||
| Date of end of reporting period | 31-Mar-2025 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Non-current assets | ||
| Property, plant and equipment | 24002000000 | ||
| Capital work-in-progress | 16490500000 | ||
| Investment property | 0 | ||
| Goodwill | 26600000 | ||
| Other intangible assets | 543700000 | ||
| Intangible assets under development | 0 | ||
| Biological assets other than bearer plants | 0 | ||
| Investments accounted for using equity method | 0 | ||
| Non-current financial assets | |||
| Non-current investments | 29800000 | ||
| Trade receivables, non-current | 0 | ||
| Loans, non-current | 19600000 | ||
| Other non-current financial assets | 155200000 | ||
| Total non-current financial assets | 204600000 | ||
| Deferred tax assets (net) | 116500000 | ||
| Other non-current assets | 2821700000 | ||
| Total non-current assets | 44205600000 | ||
| 2 | Current assets | ||
| Inventories | 9264000000 | ||
| Current financial asset | |||
| Current investments | 5079100000 | ||
| Trade receivables, current | 12738100000 | ||
| Cash and cash equivalents | 1794100000 | ||
| Bank balance other than cash and cash equivalents | 2271500000 | ||
| Loans, current | 17400000 | ||
| Other current financial assets | 185600000 | ||
| Total current financial assets | 22085800000 | ||
| Current tax assets (net) | 0 | ||
| Other current assets | 1621300000 | ||
| Total current assets | 32971100000 | ||
| 3 | Non-current assets classified as held for sale | 0 | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0 | |
| Total assets | 77176700000 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 272800000 | ||
| Other equity | 53613900000 | ||
| Total equity attributable to owners of parent | 53886700000 | ||
| Non controlling interest | 359900000 | ||
| Total equity | 54246600000 | ||
| 2 | Liabilities | ||
| Non-current liabilities | |||
| Non-current financial liabilities | |||
| Borrowings, non-current | 10257100000 | ||
| Trade payables, non-current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0 | ||
| Total Trade payable | 0 | ||
| Other non-current financial liabilities | 886000000 | ||
| Total non-current financial liabilities | 11143100000 | ||
| Provisions, non-current | 431600000 | ||
| Deferred tax liabilities (net) | 2127800000 | ||
| Deferred government grants, Non-current | 0 | ||
| Other non-current liabilities | 0 | ||
| Total non-current liabilities | 13702500000 | ||
| Current liabilities | |||
| Current financial liabilities | |||
| Borrowings, current | 1448200000 | ||
| Trade payables, current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 649200000 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 4568500000 | ||
| Total Trade payable | 5217700000 | ||
| Other current financial liabilities | 1925200000 | ||
| Total current financial liabilities | 8591100000 | ||
| Other current liabilities | 322000000 | ||
| Provisions, current | 188800000 | ||
| Current tax liabilities (Net) | 125700000 | ||
| Deferred government grants, Current | 0 | ||
| Total current liabilities | 9227600000 | ||
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0 | |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0 | |
| Total liabilities | 22930100000 | ||
| Total equity and liabilites | 77176700000 | ||
| Disclosure of notes on assets and liabilities | |||
Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results |
|||||||
|---|---|---|---|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
| Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 | |||||
| Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 | |||||
| Whether accounts are audited or unaudited | Audited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Advanced Intermediates | 6539400000 | 25273100000 | ||||
| 2 | Phenolics | 15322700000 | 58051000000 | ||||
| Total Segment Revenue | 21862100000 | 83324100000 | |||||
| Less: Inter segment revenue | 65200000 | 65200000 | |||||
| Revenue from operations | 21796900000 | 82819300000 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Advanced Intermediates | 448800000 | 1757000000 | ||||
| 2 | Phenolics | 2393300000 | 7829600000 | ||||
| Total Profit before tax | 2842100000 | 9586600000 | |||||
| i. Finance cost | 93400000 | 93400000 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | -38400000 | -38400000 | |||||
| Profit before tax | 2787100000 | 9527500000 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Advanced Intermediates | 25123200000 | 25123200000 | ||||
| 2 | Phenolics | 26421400000 | 26421400000 | ||||
| Total Segment Asset | 51544600000 | 51544600000 | |||||
| Un-allocable Assets | 25632100000 | 25632100000 | |||||
| Net Segment Asset | 77176700000 | 77176700000 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Advanced Intermediates | 5837200000 | 5837200000 | ||||
| 2 | Phenolics | 5951500000 | 5951500000 | ||||
| Total Segment Liabilities | 11788700000 | 11788700000 | |||||
| Un-allocable Liabilities | 11141400000 | 11141400000 | |||||
| Net Segment Liabilities | 22930100000 | 22930100000 | |||||
| Disclosure of notes on segments | |||||||
Other Comprehensive Income |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurements of the defined benefit plans | -17600000 | -36100000 |
| 2 | Equity Instruments through Other Comprehensive Income (FVOCI) | 2600000 | 3000000 |
| Total Amount of items that will not be reclassified to profit and loss | -15000000 | -33100000 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | -3800000 | -8600000 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Exchange Differences on translation of foreign operations | -4800000 | -8600000 |
| Total Amount of items that will be reclassified to profit and loss | -4800000 | -8600000 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0 | 0 |
| 5 | Total Other comprehensive income | -16000000 | -33100000 |
Cash flow statement, indirect |
||||||
|---|---|---|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | |||||
| A | Date of start of reporting period | 01-Apr-2024 | ||||
| B | Date of end of reporting period | 31-Mar-2025 | ||||
| C | Whether results are audited or unaudited | Audited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Part I | Blue color marked fields are non-mandatory. | |||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 9527500000 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 275000000 | |||||
| Adjustments for decrease (increase) in inventories | -1603800000 | |||||
| Adjustments for decrease (increase) in trade receivables, current | 176100000 | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0 | |||||
| Adjustments for decrease (increase) in other current assets | -975200000 | |||||
| Adjustments for decrease (increase) in other non-current assets | 0 | |||||
| Adjustments for other financial assets, non-current | 0 | |||||
| Adjustments for other financial assets, current | 0 | |||||
| Adjustments for other bank balances | 0 | |||||
| Adjustments for increase (decrease) in trade payables, current | -358500000 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0 | |||||
| Adjustments for increase (decrease) in other current liabilities | -36200000 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0 | |||||
| Adjustments for depreciation and amortisation expense | 1953700000 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 | |||||
| Adjustments for provisions, current | 83200000 | |||||
| Adjustments for provisions, non-current | 0 | |||||
| Adjustments for other financial liabilities, current | 0 | |||||
| Adjustments for other financial liabilities, non-current | 0 | |||||
| Adjustments for unrealised foreign exchange losses gains | 9000000 | |||||
| Adjustments for dividend income | 0 | |||||
| Adjustments for interest income | 364800000 | |||||
| Adjustments for share-based payments | 0 | |||||
| Adjustments for fair value losses (gains) | -248000000 | |||||
| Adjustments for undistributed profits of associates | 0 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0 | |||||
| Other adjustments to reconcile profit (loss) | 0 | |||||
| Other adjustments for non-cash items | -39500000 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Total adjustments for reconcile profit (loss) | -1129000000 | |||||
| Net cash flows from (used in) operations | 8398500000 | |||||
| Dividends received | 0 | |||||
| Interest paid | 0 | |||||
| Interest received | 0 | |||||
| Income taxes paid (refund) | 2151500000 | |||||
| Other inflows (outflows) of cash | 0 | |||||
| Net cash flows from (used in) operating activities | 6247000000 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 424100000 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 3639400000 | |||||
| Other cash receipts from sales of interests in joint ventures | 0 | |||||
| Other cash payments to acquire interests in joint ventures | 0 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Proceeds from sales of property, plant and equipment | 172100000 | |||||
| Purchase of property, plant and equipment | 11220700000 | |||||
| Proceeds from sales of investment property | 0 | |||||
| Purchase of investment property | 0 | |||||
| Proceeds from sales of intangible assets | 0 | |||||
| Purchase of intangible assets | 142300000 | |||||
| Proceeds from sales of intangible assets under development | 0 | |||||
| Purchase of intangible assets under development | 0 | |||||
| Proceeds from sales of goodwill | 0 | |||||
| Purchase of goodwill | 0 | |||||
| Proceeds from biological assets other than bearer plants | 0 | |||||
| Purchase of biological assets other than bearer plants | 0 | |||||
| Proceeds from government grants | 0 | |||||
| Proceeds from sales of other long-term assets | 0 | |||||
| Purchase of other long-term assets | 0 | |||||
| Cash advances and loans made to other parties | 0 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Dividends received | 0 | |||||
| Interest received | 336700000 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | 4400000 | |||||
| Net cash flows from (used in) investing activities | -14913300000 | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0 | |||||
| Payments from changes in ownership interests in subsidiaries | 0 | |||||
| Proceeds from issuing shares | 102200000 | |||||
| Proceeds from issuing other equity instruments | 0 | |||||
| Payments to acquire or redeem entity's shares | 0 | |||||
| Payments of other equity instruments | 0 | |||||
| Proceeds from exercise of stock options | 0 | |||||
| Proceeds from issuing debentures notes bonds etc | 0 | |||||
| Proceeds from borrowings | 9277000000 | |||||
| Repayments of borrowings | 0 | |||||
| Payments of lease liabilities | 57700000 | |||||
| Dividends paid | 1022900000 | |||||
| Interest paid | 236900000 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | -100000 | |||||
| Net cash flows from (used in) financing activities | 8061600000 | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | -604700000 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 0 | |||||
| Net increase (decrease) in cash and cash equivalents | -604700000 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 2398800000 | |||||
| Cash and cash equivalents cash flow statement at end of period | 1794100000 | |||||
Details of Impact of Audit Qualification |
|
|---|---|
| Whether results are audited or unaudited | Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | Deloitte Haskins & Sells LLP | Yes | 31-Jul-2027 | ||
|---|---|---|---|---|---|